Tag Archives: humira

Centocor v. Abbott: Fed. Cir. Takes New Written Description Requirement Out For A Spin.

In an important post-Ariad decision, the Federal Circuit reversed a district court decision that Abbott’s Humira infringed claims of a Centocor patent that could have cost Abbott $1.67 billion in damages. (A copy of the decision is at the end … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , | Leave a comment